Hydroxychloroquine has also been linked to serious side effects, including cardiac arrest, heart rhythm issues, liver failure, and kidney disorders, as noted by a 2020 FDA warning about the drug's use ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...

With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...

Real-time index price for S&P Midcap 400 (IDX), along with buy or sell indicators, analysis, charts, historical performance, ...

First, Lyn-Marié Birkholtz of the University of Pretoria in South Africa will give an introduction to the disease and describe the principles of antimalarial drug discovery that prioritizes ...

The drug was also shown to be effective in mouse ... “Astemizole is promising as an antimalarial, but still needs to be evaluated for effectiveness as an antimalarial in humans.” ...

Hastings, I. M. The origins of antimalarial drug resistance. Trends in Parasitology 20, 512 -518 (2004). Laxminarayan, R. Act now or later? Economics of malaria resistance. American Journal of ...